Cargando…
Identification of p38 MAPK as a novel therapeutic target for Friedreich’s ataxia
Friedreich ataxia (FRDA) is an autosomal recessive neuro- and cardio-degenerative disorder caused by decreased expression of frataxin, a protein that localizes to mitochondria and is critical for iron-sulfur-cluster (ISC) assembly. There are no proven effective treatments for FRDA. We previously scr...
Autores principales: | Cotticelli, M. Grazia, Xia, Shujuan, Kaur, Avinash, Lin, Daniel, Wang, Yongping, Ruff, Eric, Tobias, John W., Wilson, Robert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864720/ https://www.ncbi.nlm.nih.gov/pubmed/29568068 http://dx.doi.org/10.1038/s41598-018-23168-x |
Ejemplares similares
-
Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids
por: Cotticelli, M. Grazia, et al.
Publicado: (2013) -
Skin fibroblast metabolomic profiling reveals that lipid dysfunction predicts the severity of Friedreich’s ataxia
por: Wang, Dezhen, et al.
Publicado: (2022) -
Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893) -
Identification of telomere dysfunction in Friedreich ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2015) -
The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)